AU1508699A - Live attenuated influenza vaccine - Google Patents
Live attenuated influenza vaccineInfo
- Publication number
- AU1508699A AU1508699A AU15086/99A AU1508699A AU1508699A AU 1508699 A AU1508699 A AU 1508699A AU 15086/99 A AU15086/99 A AU 15086/99A AU 1508699 A AU1508699 A AU 1508699A AU 1508699 A AU1508699 A AU 1508699A
- Authority
- AU
- Australia
- Prior art keywords
- live attenuated
- influenza vaccine
- attenuated influenza
- vaccine
- live
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/04—Inactivation or attenuation; Producing viral sub-units
- C12N7/08—Inactivation or attenuation by serial passage of virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019970064854A KR100281676B1 (en) | 1997-11-29 | 1997-11-29 | New flu vaccine virus |
KR9764854 | 1997-11-29 | ||
PCT/KR1998/000384 WO1999028445A1 (en) | 1997-11-29 | 1998-11-30 | Live attenuated influenza vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1508699A true AU1508699A (en) | 1999-06-16 |
Family
ID=19526120
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU15086/99A Abandoned AU1508699A (en) | 1997-11-29 | 1998-11-30 | Live attenuated influenza vaccine |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100281676B1 (en) |
AU (1) | AU1508699A (en) |
WO (1) | WO1999028445A1 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0410702B1 (en) * | 2003-05-28 | 2022-04-12 | Wisconsin Alumni Research Foundation | Composition, methods for preparing an influenza virus and gene delivery vehicle, and viruses |
JP4558652B2 (en) | 2003-06-20 | 2010-10-06 | マイクロビクス・バイオシステムズ・インコーポレイテツド | Improved virus production |
KR101316350B1 (en) | 2004-12-08 | 2013-10-15 | 메디뮨 엘엘씨 | Methods of producing influenza vaccine compositions |
WO2007126810A2 (en) | 2006-03-31 | 2007-11-08 | Warf - Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
EP2170382B1 (en) * | 2007-06-15 | 2013-07-31 | Protheon Co., Ltd. | Live vaccine comprising an attenuated influenza virus |
US9474798B2 (en) | 2007-06-18 | 2016-10-25 | Wisconsin Alumni Research Foundation | Influenza M2 protein mutant viruses as live influenza attenuated vaccines |
JP2013507990A (en) | 2009-10-26 | 2013-03-07 | ダブリュエーアールエフ−ウィスコンシン アラムナイ リサーチ ファウンデーション | High-titer recombinant influenza virus with enhanced replication in Vero cells |
US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
WO2011136421A1 (en) * | 2010-04-30 | 2011-11-03 | 주식회사 바이오트라이온 | Novel primer and method for preparing a recombinant influenza virus using same |
KR101481986B1 (en) | 2012-07-23 | 2015-01-19 | 연세대학교 산학협력단 | Live vaccine protecting against pathogenic avian influenza H5N1 and use thereof |
KR101443983B1 (en) * | 2012-12-04 | 2014-11-03 | 충북대학교 산학협력단 | A multiple mutated influenza A virus for MDCK cell specific proliferation improvement |
EP3022296B1 (en) | 2013-07-15 | 2022-12-28 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs |
WO2015196150A2 (en) | 2014-06-20 | 2015-12-23 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
US10633422B2 (en) | 2015-06-01 | 2020-04-28 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA |
CN107949636B (en) | 2015-06-04 | 2021-11-09 | 香港大学 | Live attenuated viruses and methods of production and use |
US9890363B2 (en) | 2015-07-06 | 2018-02-13 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
US11197925B2 (en) | 2016-02-19 | 2021-12-14 | Wisconsin Alumni Research Foundation (Warf) | Influenza B virus replication for vaccine development |
EP3914295A2 (en) | 2019-01-23 | 2021-12-01 | Yoshihiro Kawaoka | Mutations that confer genetic stability to additional genes in influenza viruses |
CN113874496A (en) | 2019-02-08 | 2021-12-31 | 威斯康星校友研究基金会(Warf) | Humanized cell lines |
CN114929269A (en) | 2019-05-01 | 2022-08-19 | 威斯康星校友研究基金会(Warf) | Improved influenza virus replication for vaccine development |
WO2021041624A2 (en) | 2019-08-27 | 2021-03-04 | Yoshihiro Kawaoka | Recombinant influenza viruses with stabilized ha for replication in eggs |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2084525C1 (en) * | 1995-09-05 | 1997-07-20 | Научно-исследовательский институт экспериментальной медицины РАМН | Attenuated cold-adapted strain of influenza virus b ussr(69)e for preparing the live intranasal antiinfluenza vaccine |
-
1997
- 1997-11-29 KR KR1019970064854A patent/KR100281676B1/en not_active IP Right Cessation
-
1998
- 1998-11-30 WO PCT/KR1998/000384 patent/WO1999028445A1/en active Application Filing
- 1998-11-30 AU AU15086/99A patent/AU1508699A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999028445A1 (en) | 1999-06-10 |
KR100281676B1 (en) | 2001-04-02 |
KR19990043809A (en) | 1999-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6065998A (en) | Influenza vaccine | |
AU1308495A (en) | Influenza vaccine | |
AU1508699A (en) | Live attenuated influenza vaccine | |
GB9711964D0 (en) | Live attenuated vaccines | |
AU9623898A (en) | Vaccines | |
GB2337755B (en) | Virus vaccine | |
AU4781297A (en) | Vaccines | |
GB9712347D0 (en) | Vaccine | |
GB9727262D0 (en) | Vaccine | |
GB9711990D0 (en) | Vaccine | |
GB9726555D0 (en) | Vaccine | |
GB9720585D0 (en) | Vaccine | |
AU4520397A (en) | Attenuated live neospora vaccine | |
AU4204097A (en) | Vaccine composition against malaria | |
AU1285300A (en) | Hiv vaccine | |
AU2462899A (en) | Live vaccine against brucellosis | |
AU3552797A (en) | Vaccine preparations | |
AU6158700A (en) | Vaccine | |
AU7915398A (en) | An influenza enveloped dna vaccine | |
AU4489896A (en) | Avian recombinant live vaccine | |
AU2144499A (en) | Live attenuated salmonella vaccine | |
AU6075498A (en) | Vaccines | |
ZA984696B (en) | Vaccine compositions V. | |
AU3452997A (en) | Vaccine compositions | |
GB9702990D0 (en) | Virus vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |